1. Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review

   • Yoshitaka Nishikawa
   • Nobuaki Hoshino
   • Takeo Nakayama

   Invited Review Article 24 May 2020 Pages: 1441 - 1449

   

2. Progress on treatment of MET signaling pathway in non-small cell lung cancer

   • Xiaoqing Yu
   • Sizhe Yu
   • Yun Fan

   Review Article 21 May 2020 Pages: 1450 - 1458

3. Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis

   • Keiichiro Mori
   • Noriyoshi Miura
   • Shahrokh F. Shariat

   Review Article Open access 26 May 2020 Pages: 1459 - 1474

   

4. Survival outcomes following craniotomy for intracranial metastases from an unknown primary

   • Melissa Gough
   • Molly Nielsen
   • Damian Holliman

   Original Article Open access 01 May 2020 Pages: 1475 - 1482

   

5. Survival prediction and treatment strategies for patients with advanced laryngeal carcinoma: a population-based study

   • Xiaoke Zhu
   • Yu Heng
   • Lei Tao

   Original Article 27 May 2020 Pages: 1483 - 1491

   

6. Hand-foot syndrome and survival in patients with advanced non-small-cell lung cancer receiving anlotinib: a subgroup analysis of data from the ALTER 0303 study

   • Xueli Nan
   • Chao Xie
   • Jie Liu

   Original Article 24 May 2020 Pages: 1492 - 1498

   

7. Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer

   • Liuwei Tang
   • Yojiro Ishikawa
   • Keiichi Jingu

   Original Article 30 April 2020 Pages: 1499 - 1505

   

8. Prognostic significance of preoperative plasma fibrinogen levels in primary gastrointestinal stromal tumours: a retrospective cohort study

   • Shibo Song
   • Xianglong Cao
   • Gang Xiao

   Original Article 23 June 2020 Pages: 1506 - 1514

   

9. Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study)

   • Masahito Kotaka
   • Shigeyoshi Iwamoto
   • Naohiro Tomita

   Original Article 14 May 2020 Pages: 1515 - 1522

   

10. Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy

    • Takeshi Yamada
    • Akihisa Matsuda
    • Hiroshi Yoshida

    Original Article 11 May 2020 Pages: 1523 - 1532

    

11. A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

    • Nobuyuki Hinata
    • Junji Yonese
    • Hirotsugu Uemura

    Original Article Open access 09 June 2020 Pages: 1533 - 1542

    

12. Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes

    • Kazuyuki Numakura
    • Mizuki Kobayashi
    • Tomonori Habuchi

    Original Article 11 May 2020 Pages: 1543 - 1550

    

13. Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma

    • Ho Won Kang
    • Sung Pil Seo
    • The KORCC (KOrean Renal Cell Carcinoma) Group

    Original Article 05 June 2020 Pages: 1551 - 1561